April 1, 2011 -- Shanghai Pharmaceuticals Holding, one of China’s two biggest drug distribution companies, will apparently increase the size of its massive Hong Kong IPO by as much as 50%. Originally the company planned to raise $1.2 billion. Now it is proposing to expand the offering to $1.5 billion or $1.8 billion. The price per share appears to be unchanged from the 17.6 RMB specified in the first reports from last September. Apparently, the company will offer a bigger stake in the company than the 25% of capitalization originally proposed. More details....
